+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Veracyte Inc (VCYT) - Product Pipeline Analysis, 2021 Update

  • ID: 5367345
  • Company Profile
  • June 2021
  • 37 pages
  • GlobalData
  • Veracyte Inc

FEATURED COMPANIES

  • Endocyte Inc
  • GeneThera Inc
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Veracyte Inc (Veracyte) is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The company’s pipeline products comprise Afirma thyroid FNA analysis for the diagnosis of thyroid cancer based on its proprietary afirma gene expression classifier. It also provides percepta bronchial genomic classifier an assay to evaluate patients with lung nodules that are suspected for cancer. Veracyte offers genomic testing to other areas of substantial clinical need with diagnostic ambiguity. The company markets its afirma solutions through its sales force across in the US. It also commercializes its products in Brazil. Veracyte is headquartered in South San Francisco, California, the US

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and helps to create effective counter strategies to gain a competitive advantage.

Scope
  • The report reviews the detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Veracyte Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides a detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Endocyte Inc
  • GeneThera Inc
  • MORE
Veracyte Inc Company Overview
  • Veracyte Inc Company Snapshot
  • Veracyte Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Veracyte Inc - Pipeline Analysis Overview
  • Veracyte Inc - Key Facts
  • Veracyte Inc - Major Products and Services
  • Veracyte Inc Pipeline Products by Development Stage
Veracyte Inc Pipeline Products Overview
  • Afirma - Risk of Recurrence
  • Afirma - Risk of Recurrence Product Overview
  • Afirma - Thyroid Cancer Staging/ Prognosis Test
  • Afirma - Thyroid Cancer Staging/ Prognosis Test Product Overview
  • Afirma Xpression Atlas - Pulmonology
  • Afirma Xpression Atlas - Pulmonology Product Overview
  • BronchoGen Test
  • BronchoGen Test Product Overview
  • Comprehensive Genomic Profiling Test
  • Comprehensive Genomic Profiling Test Product Overview
  • Diagnostic Assay - Renal Cancer
  • Diagnostic Assay - Renal Cancer Product Overview
  • Disease Diagnosis Device
  • Disease Diagnosis Device Product Overview
  • Envisia - Disease Progression Test
  • Envisia - Disease Progression Test Product Overview
  • Envisia - Rx Response Test
  • Envisia - Rx Response Test Product Overview
  • Nasal Swab Classifier - Lung Cancer
  • Nasal Swab Classifier - Lung Cancer Product Overview
  • nCounter Dx LymphMark Assay
  • nCounter Dx LymphMark Assay Product Overview
  • nCounter FLEX Analysis System - Idiopathic Pulmonary Fibrosis Test
  • nCounter FLEX Analysis System - Idiopathic Pulmonary Fibrosis Test Product Overview
  • Percepta Atlas
  • Percepta Atlas Product Overview
Veracyte Inc - Key Competitors

Veracyte Inc - Key Employees

Veracyte Inc - Locations and Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Recent Developments
  • Veracyte Inc, Recent Developments
  • Jun 02, 2021: Veracyte to Present at Upcoming Investor Conferences
  • May 10, 2021: Veracyte Announces First Quarter 2021 Financial Results
  • May 10, 2021: Veracyte Announces CEO Succession Plan
  • Apr 15, 2021: Veracyte Announces Retirement of CFO and Preliminary First Quarter 2021 Financial Results
  • Apr 02, 2021: Veracyte to Present at 20th Annual Needham Virtual Healthcare Conference
  • Mar 22, 2021: Veracyte Appoints Muna Bhanji to Its Board of Directors
  • Feb 10, 2021: Veracyte to Release Fourth Quarter and Full-Year 2020 Financial Results on February 17, 2021
  • Jan 06, 2021: Veracyte to Participate in 23rd Annual Needham Virtual Growth Conference
  • Nov 18, 2020: Bayer initiates new G4A Digital Health Partnerships Program
  • Oct 22, 2020: IDEAYA announces partnership with The Broad Institute and advancement of synthetic Lethality programs and platform
Appendix
  • Methodology
  • About the Publisher
List of Tables
  • Veracyte Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Veracyte Inc Pipeline Products by Equipment Type
  • Veracyte Inc Pipeline Products by Indication
  • Veracyte Inc, Key Facts
  • Veracyte Inc, Major Products and Services
  • Veracyte Inc Number of Pipeline Products by Development Stage
  • Veracyte Inc Pipeline Products Summary by Development Stage
  • Afirma - Risk of Recurrence - Product Status
  • Afirma - Risk of Recurrence - Product Description
  • Afirma - Thyroid Cancer Staging/ Prognosis Test - Product Status
  • Afirma - Thyroid Cancer Staging/ Prognosis Test - Product Description
  • Afirma Xpression Atlas - Pulmonology - Product Status
  • Afirma Xpression Atlas - Pulmonology - Product Description
  • BronchoGen Test - Product Status
  • BronchoGen Test - Product Description
  • Comprehensive Genomic Profiling Test - Product Status
  • Comprehensive Genomic Profiling Test - Product Description
  • Diagnostic Assay - Renal Cancer - Product Status
  • Diagnostic Assay - Renal Cancer - Product Description
  • Disease Diagnosis Device - Product Status
  • Disease Diagnosis Device - Product Description
  • Envisia - Disease Progression Test - Product Status
  • Envisia - Disease Progression Test - Product Description
  • Envisia - Rx Response Test - Product Status
  • Envisia - Rx Response Test - Product Description
  • Nasal Swab Classifier - Lung Cancer - Product Status
  • Nasal Swab Classifier - Lung Cancer - Product Description
  • nCounter Dx LymphMark Assay - Product Status
  • nCounter Dx LymphMark Assay - Product Description
  • nCounter FLEX Analysis System - Idiopathic Pulmonary Fibrosis Test - Product Status
  • nCounter FLEX Analysis System - Idiopathic Pulmonary Fibrosis Test - Product Description
  • Percepta Atlas - Product Status
  • Percepta Atlas - Product Description
Veracyte Inc, Key Employees
  • Veracyte Inc, Other Locations
  • Veracyte Inc, Subsidiaries
  • Glossary
List of Figures
  • Veracyte Inc Pipeline Products by Equipment Type
  • Veracyte Inc Pipeline Products by Development Stage
Note: Product cover images may vary from those shown
  • Kerma Medical Products Inc
  • Lifelines Neurodiagnostic Systems Inc
  • GeneThera Inc
  • Endocyte Inc
Note: Product cover images may vary from those shown
Adroll
adroll